Q&M Dental Group - Maybank Kim Eng 2021-09-14: The New Normal

Q & M DENTAL GROUP (S) LIMITED (SGX:QC7) | SGinvestors.io Q & M DENTAL GROUP (S) LIMITED (SGX:QC7)

Q&M Dental Group - The New Normal


Recent Q&M Dental share price weakness creates buying opportunity

  • Q&M Dental's share price has pulled back by > 20% from recent peak post its 2Q21 results on profit taking, along with general market weakness. Given no change in earnings outlook, we see the current share price as a good entry level and provides a window of opportunity for those investors that missed the previous rally.
  • Following the completion of 1:5 bonus issue (see Q&M Dental's corporate actions), our target price for Q&M Dental (SGX:QC7) has been adjusted to S$0.85, still pegged at 22x FY22E P/E (~20% discount to peers’ average). With 49% upside potential, maintain BUY.



COVID-19 testing set to become the new norm

  • According to Minister Lawrence Wong, Singapore will stay in the current preparatory stage of its reopening, and will continue to rely on vaccination and testing to keep the COVID-19 situation under control amid a recent spike in infections.
  • With about 85% of the population likely to be fully vaccinated by the end of Sep, Mr Wong said Singapore should aspire to be a nation of testing, where testing becomes a way of life in this endemic.


Increases frequency/coverage of mandatory tests

  • In fact, Singapore is increasing the frequency of COVID-19 malls and supermarkets as well as delivery personnel and transport workers.


Q&M is on track to deliver strong 2H21 earnings


  • See also Q&M Dental's ESG metrics and issues in report attached below.




Eric Ong Maybank Kim Eng Research | https://www.maybank-ke.com.sg/ 2021-09-14
SGX Stock Analyst Report BUY MAINTAIN BUY 0.85 DOWN 1.030



Advertisement



MOST TALKED ABOUT STOCKS / REITS OF THE WEEK



loading.......



ANALYSTS SAY


loading.......